Key facts
- It has raised $44.5M across 3 recorded rounds; the latest was Early Stage VC ($35.4M) in Apr 2022.
- Candesant Biomedical has filed 2 Form Ds with the SEC since 2020, most recently Jun 2023 ($35.4M sold to 59 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·Watchlist + deal alerts for Candesant Biomedical
Create free account
No card required
Funding rounds
3 roundsJan 2018Accelerator/Incubator—▮
About Candesant Biomedical
- Industry
- Other Devices and Supplies
PA Mark — not yet priced
Candesant Biomedical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Candesant Biomedical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Candesant Biomedical in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.